EDN1 and cancer: Receptor blockade by specific antagonists inhibits the proliferative effects of ET-1 in cancer cells (Nelson et al, 2003) and reverses ET-1-mediated cell survival during chemotherapy-induced apoptosis (Pflug et al, 2007).